doi:10.1016/j.explore.2021.09.006 Pakowska-Godzik E, Lachowicz K, Rosoowska-Huszcz D
Here's something the internet won't tell you when it sells you research-grade powder: with an unregulated compound, what's in the bottle matters as much as the molecule itself
Food and Drug Administration)
b) by stimulating the production of prostaglandins and leukotrienes, which are anti-inflammatory molecules [81]
For GHK-Cu wound healing, this means explicitly communicating: GHK-Cu is not FDA-approved as a drug for any indication Human wound-healing evidence is limited to small, non-randomized studies The compounding pharmacy source is not subject to the same oversight as FDA-approved manufacturers Alternative, evidence-based wound-healing options exist (negative pressure wound therapy, growth factor therapies like becaplermin, advanced wound dressings) Monitoring will be required, with associated lab costs Document this conversation in the medical record